| ACST Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACST shares outstanding history going back to 10/15/2015:
Also see: ACST Market Cap History ACST YTD Return |
ACST Shares Outstanding History — Acasti Pharma Share Count Over Time
As of 6/23/2023 Acasti Pharma has 7.44 million ACST shares outstanding. Investors often track the ACST shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ACST share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 10/15/2015.
| ACST Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
ACST Historical Shares Outstanding: +57.83% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| ACST Stock Price Chart |
| About Grace Therapeutics Inc |
| Acasti Pharma is a biopharmaceutical company that is focused on developing and commercializing products for rare and orphan diseases by using its drug delivery technologies. Co.'s primary drug candidate, GTX-104, is an IV formulation of nimodipine designed to treat subarachnoid hemorrhage, a rare brain disorder. Co.'s other drug candidates are: GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia, an orphan pediatric genetic neurodegenerative disorder in young children; and GTX-101, which is a topical bioadhesive film-forming bupivacaine spray for Postherpetic Neuralgia, which causes debilitating pain following infection by the shingles virus. We show 20 historical shares outstanding datapoints in our coverage of ACST's shares outstanding history. Understanding the changing numbers of ACST shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACST versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACST by allowing them to research ACST shares outstanding history as well as any other stock in our coverage universe. |
| ACST Current Stock Quote |
Quotes delayed 20 minutes  Free ACST Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ACST Share Performance |
| Shares Outstanding Peers |
| Acasti Pharma (ACST) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACTU Shares Outstanding History ACXP Shares Outstanding History ADGI Shares Outstanding History ADIL Shares Outstanding History ADMA Shares Outstanding History ADMP Shares Outstanding History ADMS Shares Outstanding History ADPT Shares Outstanding History ADRO Shares Outstanding History ADTX Shares Outstanding History More Healthcare companies » |
ACST Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
